Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

National Institutes of Health

Federal funding opportunity RFA-NS-26-001 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.